Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot‐Delettre, Anne Roggy, Arthur E. Frankel, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 223-230
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Marco Ruella, David M. Barrett, Saad S. Kenderian, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 10, pp. 3814-3826
Open Access | Times Cited: 510
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
Marco Ruella, Michael Klichinsky, Saad S. Kenderian, et al.
Cancer Discovery (2017) Vol. 7, Iss. 10, pp. 1154-1167
Open Access | Times Cited: 175
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Ugo Testa, Elvira Pelosi, Germana Castelli
Cancers (2019) Vol. 11, Iss. 9, pp. 1358-1358
Open Access | Times Cited: 128
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 110
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
Evgeniya Angelova, Charlene A. Audette, Yelena Kovtun, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 749-755
Open Access | Times Cited: 64
Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
Francesco Borriello, Maria Rosaria Galdiero, Gilda Varricchi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 834-834
Open Access | Times Cited: 63
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Konopleva
Blood Advances (2020) Vol. 4, Iss. 16, pp. 4020-4027
Open Access | Times Cited: 58
IL-3 in the development and function of basophils
Gilda Varricchi, Remo Poto, Gianni Marone, et al.
Seminars in Immunology (2021) Vol. 54, pp. 101510-101510
Closed Access | Times Cited: 41
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
Adam Ceroi, David Masson, Anne Roggy, et al.
Blood (2016) Vol. 128, Iss. 23, pp. 2694-2707
Open Access | Times Cited: 55
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 52
In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Roddy S. O’Connor
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 7, pp. 1223-1233
Open Access | Times Cited: 34
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
Naveen Pemmaraju, Branko Cuglievan, Joseph A. Lasky, et al.
eJHaem (2024) Vol. 5, Iss. 1, pp. 61-69
Open Access | Times Cited: 5
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Laure Philippe, Adam Ceroi, Elodie Bôle‐Richard, et al.
Haematologica (2017) Vol. 102, Iss. 11, pp. 1861-1868
Open Access | Times Cited: 43
A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
Sophie E. Broughton, Timothy R. Hercus, Tracy L. Nero, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Tagraxofusp: First Global Approval
Yahiya Y. Syed
Drugs (2019) Vol. 79, Iss. 5, pp. 579-583
Closed Access | Times Cited: 38
CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies
Hanadi El Achi, Édouard Dupont, Shilpa Paul, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3087-3087
Open Access | Times Cited: 38
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
Elodie Bôle‐Richard, Maxime Fredon, Sabeha Biichlé, et al.
Leukemia (2020) Vol. 34, Iss. 12, pp. 3228-3241
Closed Access | Times Cited: 34
Role of the β Common (βc) Family of Cytokines in Health and Disease
Timothy R. Hercus, Winnie L. Kan, Sophie E. Broughton, et al.
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 6, pp. a028514-a028514
Open Access | Times Cited: 38
A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
Arghya Ray, Deepika Sharma Das, Yan Song, et al.
Leukemia (2017) Vol. 31, Iss. 12, pp. 2652-2660
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top